Baihakke, Norsina S.
HRN: 23-99-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2024
CLINDAMYCIN 300MG (CAP)
09/17/2024
09/24/2024
PO
300mg
TID
Cellulitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes